Koninklijke Philips N.V. NY Registry Shares (PHG)

Total Non-Current Liabilities

€7.80B

Quarterly · Period ending: · EUR

PHG logo

PHG Total Non-Current Liabilities

Latest reported€7.80B EUR
PHG Quarterly Total Non-Current Liabilities · EUR (€6.89B → €7.80B)
High-resolution chart · PNG

PHG total non-current liabilities history

Quarterly · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

Koninklijke Philips N.V. NY Registry Shares Total Non-Current Liabilities — Quarterly (EUR)
Period endingTotal Non-Current Liabilities (EUR)
7,802,000,000
8,425,778,000
8,446,000,000
8,726,000,000
8,770,000,000
8,682,000,000
8,789,000,000
-11,919,000,000
8,793,000,000
-12,061,000,000
9,059,000,000
-12,160,000,000
9,275,000,000
-13,283,000,000
9,471,000,000
-14,766,000,000
9,294,000,000
-14,474,000,000
9,037,000,000
-11,986,000,000
8,249,000,000
-11,901,000,000
8,076,000,000
-10,981,000,000
9,011,000,000
-12,625,000,000
7,413,000,000
0
7,291,000,000
0
5,959,000,000
0
6,001,000,000
0
6,427,000,000
7,279,000,000
5,299,000,000
8,032,000,000
8,322,000,000
9,266,000,000
9,876,000,000
8,505,000,000
9,128,000,000
8,970,000,000
9,386,000,000
9,663,000,000
8,157,000,000
7,510,000,000
6,662,000,000
6,745,000,000
6,856,000,000
7,243,000,000
7,407,000,000
7,696,000,000
7,950,000,000
7,887,000,000
8,111,000,000
7,930,000,000
7,234,000,000
6,415,000,000
6,061,000,000
6,110,000,000
6,419,000,000
6,684,000,000
7,682,000,000
7,917,000,000
7,833,000,000
7,291,000,000
7,690,000,000
7,759,000,000
7,824,000,000
7,331,723,990
7,509,112,650
7,701,489,970
4,991,761,860
4,550,800,380
4,631,349,130
6,168,134,400
6,238,819,460
5,945,946,160
6,103,497,400
6,167,774,760
6,482,612,180
6,340,317,320
6,523,195,140
6,415,211,880
6,400,849,360
6,564,521,340
6,953,063,040
7,184,002,660
6,808,807,250
7,095,277,350
7,809,822,460
9,005,144,750
9,073,227,370
11,248,627,280
7,795,110,400
12,082,216,300
8,894,623,740
11,884,797,900
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.